Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471909 · ClinicalTrials.gov registry record · NA
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
A NA study of Aortic Aneurysm and Aortic Dissection, sponsored by Endospan.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 20
- Study locations
NCT04471909 is a NA study of Aortic Aneurysm and Aortic Dissection that is actively recruiting participants, run by Endospan. The registered enrollment target is 110 participants, below the 632-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (83% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT04471909, a NA study of Aortic Aneurysm and Aortic Dissection, is actively recruiting participants, sponsored by Endospan.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.
Conditions Studied
Interventions
- DEVICE NEXUS Aortic Stent Graft System
Study Locations (20)
California
- University of California San Diego Medical Center - La Jolla
- UC Davis Health - Sacramento
- Stanford University School of Medicine - Stanford
North Carolina
- University of North Carolina - Chapel Hill
- Atrium Health - Charlotte
- Duke University Medical Center - Durham
New York
- The Mount Sinai Medical Center - New York
- Northwell Health Lenox Hill Hospital - New York
Alabama
- University of Alabama Birmingham - Birmingham
Colorado
- University of Colorado - Aurora
Connecticut
- Hartford Hospital - Hartford
District of Columbia
- MedStar Washington Hospital - Washington D.C.
Florida
- Advent Health Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2029-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471909
The ClinicalTrials.gov registry entry for NCT04471909 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 632-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (83% lower). The listed sponsor is Endospan, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which NEXUS Aortic Stent Graft System is the first listed.
NCT04471909 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, North Carolina, New York.
Frequently Asked Questions
What is clinical trial NCT04471909 about?
NCT04471909 is a clinical study titled "NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness". Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with ...
What is the current status of trial NCT04471909?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2020-10-20. Estimated completion is 2029-10.
What conditions does trial NCT04471909 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Aortic Dissection, Intramural Hematoma, Penetrating Aortic Ulcer.
What interventions are being tested in trial NCT04471909?
The interventions under investigation include: NEXUS Aortic Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT04471909?
This trial is sponsored by Endospan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04471909 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise Physiology in Patients With Aortic Aneurysm and Its Correlation With Mechanical Properties of Aortic Tissue
RECRUITING · NA
-
Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms
RECRUITING · NA
-
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
RECRUITING · NA
-
Prehabilitation for Aortic Aneurysm Surgery: Proof-of-concept Trial
RECRUITING · NA
-
Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
RECRUITING · NA
-
Laser In Situ Fenestration Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.